204254-96-6Relevant articles and documents
Method for preparing oseltamivir intermediate
-
Paragraph 0031-0034; 0039-0071, (2021/06/26)
The invention relates to a preparation method of an oseltamivir intermediate (as shown in a formula IV). The method is prepared through a route as described in the specification. The method is simple and safe to operate, short in synthetic route, high in yield, small in environmental pollution, good in economic effect and suitable for industrial production.
METHOD FOR PREVENTING OR TREATING ARRHYTHMIA, METHOD FOR PREVENTING OR TREATING ATRIAL FIBRILLATION, MODEL OF SUSTAINED ATRIAL FIBRILLATION, METHOD FOR PRODUCING THE MODEL, AND METHOD FOR SCREENING FOR ATRIAL FIBRILLATION INHIBITOR
-
, (2014/03/24)
A method for preventing or treating atrial fibrillation, including: administering, to an individual, an atrial fibrillation inhibitor containing a compound expressed by one of the following Structural Formulas (I) to (VI) or a pharmacologically acceptable salt thereof: where in the Structural Formula (III), Gluc refers to glucuronic acid,
EPOXIDE INTERMEDIATE IN THE TAMIFLU SYNTHESIS
-
Page/Page column 18; 23, (2008/06/13)
The present invention relates to technology for preparing derivatives of unsaturated, cyclic, organic acids and salts, thereof. Shikimic acid is an example of such an acid. More particularly, the present invention relates to preparing derivatives of these acids or salts thereof that are esterified, ketalized, functionalized with a leaving group, and/or provided with epoxide functionality. Preferred aspects may be used in the synthesis of Oseltamivir Phosphate starting from shikimic acid.